ctrl K

Price Alert

Palvella Therapeutics Inc... (PVLA)

NASDAQ: PVLA · Real-Time Price · USD

47.12

1.02 (2.21%)

At close: Aug 15, 2025, 3:59 PM

48.00

1.88%

After-hours: Aug 15, 2025, 05:20 PM EDT

Palvella Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	83.6M	7.35M	16.05M	117.76M
Short-Term Investments	n/a	n/a	20.53M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	22.07M	2.9M
Receivables	2.34M	n/a	5.81M	3.31M
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	2.3M	198K	-5.34M	6.55M
Total Current Assets	88.23M	7.55M	16.52M	127.63M
Property-Plant & Equipment	n/a	n/a	n/a	23.03M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	22.07M	25.93M
Total Assets	88.23M	7.55M	16.52M	153.56M
Account Payables	4.59M	936K	3.18M	8.61M
Deferred Revenue	n/a	n/a	n/a	25.12M
Short-Term Debt	n/a	n/a	859K	1.05M
Other Current Liabilities	6.24M	344K	62K	12.21M
Total Current Liabilities	12.04M	2.36M	5.78M	50.56M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	13.59M	9.07M	n/a	n/a
Total Long-Term Liabilities	13.59M	9.07M	33.92M	52.24M
Total Liabilities	25.63M	11.43M	39.7M	102.81M
Total Debt	11.94M	78.66M	13.1M	14.89M
Common Stock	11K	n/a	74K	72K
Retained Earnings	-93.73M	-76.3M	-94.99M	-257.14M
Comprehensive Income	3K	28K	-254K	829K
Shareholders Equity	62.61M	-3.88M	-23.17M	50.76M
Total Investments	n/a	n/a	20.53M	n/a